![PRD_000275 PRD_000275](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000275.svg) | PRD_000275 | Name: | Ac-DADE-F(2)Pmp-L-NH(2) | Formula: | C32 H46 F2 N7 O15 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000276 PRD_000276](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000276.svg) | PRD_000276 | Name: | Thrombostatin FM inhibitor [rOicPaF(p-Me)] | Formula: | C33 H52 N9 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000277 PRD_000277](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000277.svg) | PRD_000277 | Name: | N-[(benzyloxy)carbonyl]-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]-L-valinamide | Formula: | C27 H35 Cl N4 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000278 PRD_000278](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000278.svg) | PRD_000278 | Name: | DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE | Formula: | C34 H71 Cl N11 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000280 PRD_000280](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000280.svg) | PRD_000280 | Name: | HIV ENTRY INHIBITOR PIE1 | Formula: | C80 H118 N22 O22 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000281 PRD_000281](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000281.svg) | PRD_000281 | Name: | HIV ENTRY INHIBITOR PIE7 | Formula: | C81 H110 N20 O22 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000282 PRD_000282](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000282.svg) | PRD_000282 | Name: | N-acetyl-L-alpha-aspartyl-L-asparaginyl-N-[(1R)-2-carboxy-1-formylethyl]-L-leucinamide | Formula: | C20 H33 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000284 PRD_000284](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000284.svg) | PRD_000284 | Name: | AC-DQMD-CHO | Formula: | C20 H33 N5 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000285 PRD_000285](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000285.svg) | PRD_000285 | Name: | L-tryptophyl-L-tyrosyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-threoninamide | Formula: | C31 H44 Cl N8 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000286 PRD_000286](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000286.svg) | PRD_000286 | Name: | D-valyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-L-leucinamide | Formula: | C18 H36 Cl N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000289 PRD_000289](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000289.svg) | PRD_000289 | Name: | BETA-SECRETASE INHIBITOR OM00-3 | Formula: | C44 H69 N7 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000290 PRD_000290](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000290.svg) | PRD_000290 | Name: | BETA-SECRETASE INHIBITOR OM99-2 | Formula: | C41 H64 N8 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000293 PRD_000293](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000293.svg) | PRD_000293 | Name: | INHIBITOR AC-ESMD-CHO | Formula: | C19 H32 N4 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000295 PRD_000295](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000295.svg) | PRD_000295 | Name: | GLU-VAL-DEHYDROXYMETHYLASPARTIC ACID INHIBITOR | Formula: | C23 H30 Cl N3 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000296 PRD_000296](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0GQ.svg) | PRD_000296 | Name: | 4-amino-N-{(1R,8R,9R,13R)-16-(4-amino-2-methylpyrimidin-5-yl)-1-benzyl-8-(cyclohexylmethyl)-9-hydroxy-13-[(1S)-1-methylpropyl]-2,6,11,14-tetraoxo-3,7,12,15-tetraazahexadec-1-yl}piperidine-1-carboxamide | Formula: | C41 H64 N10 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000298 PRD_000298](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000298.svg) | PRD_000298 | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | Formula: | C58 H72 N12 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000300 PRD_000300](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000300.svg) | PRD_000300 | Name: | N-acetyl-L-isoleucyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-prolinamide | Formula: | C22 H36 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000301 PRD_000301](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000301.svg) | PRD_000301 | Name: | N-(2-oxoethyl)-L-isoleucyl-L-alpha-glutamyl-N-[(1R)-2-carboxy-1-formylethyl]-L-threoninamide | Formula: | C21 H36 N4 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000306 PRD_000306](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000306.svg) | PRD_000306 | Name: | KPFS-(CH2-NH)-LQF peptidomimetic inhibitor of PfPM1 | Formula: | C49 H77 N10 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000307 PRD_000307](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000307.svg) | PRD_000307 | Name: | N-acetyl-6-ammonio-L-norleucyl-L-glutaminyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-leucinamide | Formula: | C26 H52 Cl N9 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000309 PRD_000309](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000309.svg) | PRD_000309 | Name: | L-leucyl-N-(2-oxopropyl)-L-phenylalaninamide | Formula: | C26 H31 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000313 PRD_000313](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000313.svg) | PRD_000313 | Name: | MeOSuc-Ala-Ala-Pro-boroIle | Formula: | C21 H37 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000314 PRD_000314](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000314.svg) | PRD_000314 | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID | Formula: | C18 H31 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000315 PRD_000315](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000315.svg) | PRD_000315 | Name: | O-methylsuccinyl-alanyl-alanyl-prolyl-borophenylalanine | Formula: | C24 H35 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000316 PRD_000316](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000316.svg) | PRD_000316 | Name: | METHOXYSUCCINYL-ALA-ALA-PRO-VALINE BORONIC ACID | Formula: | C20 H35 B N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|